Mutational Analysis of the NPHS2 Gene in Czech Patients with Idiopathic Nephrotic Syndrome (nephroticsyndrome/NPHS2gene/focalsegmentalglomerulosclerosis/mutation/polymorphism)

Focal segmental glomerulosclerosis and minimal change disease represent frequent histological patterns of renal injury in patients with nephrotic syndrome. Few cases carrying NPHS2 gene variants have been described to date. Mutational analysis of the NPHS2 gene was performed in 50 Czech adult patients with histologically proved FSGS/MCD. The common p.P20L and p.R229Q polymorphisms of the NPHS2 gene were tested in 169 patients with IgA nephropathy and in 300 individuals of the control group. No mutation in the NPHS2 gene in patients with adult onset was identified. One homozygous mutation p.V290M in a patient with onset in early childhood was found. One new heterozygous variant in the non-conservative area of the NPHS2 gene, p.G97S, was identified in a patient with childhood-onset FSGS. In one adult patient, there were two polymorphisms, p.P20L and p.R229Q, in trans-heterozygous state, which could contribute to steroid-resistant nephrotic syndrome. The most common polymorphism p.R229Q was identified in 12 % of FSGS/ MCD patients, in 11.8 % of IGAN patients and in 10% of controls. The heterozygosity of p.R229Q polymorphism was similar in the IGAN group, with non-significantly higher prevalence in IGAN patients with progressive form of the disease (15.9 % versus 9.4 %). The prevalence of p.P20L polymorphism was not significantly different among the groups (6 % in FSGS patients, 1.8 % in IGAN patients, 1 % in the control group). To conclude, NPHS2 mutations are rare in patients with adult onset of FSGS/MCD. The R229Q polymorphism is frequent in the Czech population and probably could have some influence on IGAN.

[1]  C. Antignac,et al.  Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. , 2011, The Journal of clinical investigation.

[2]  G. Remuzzi,et al.  MYO1E mutations and childhood familial focal segmental glomerulosclerosis. , 2011, The New England journal of medicine.

[3]  A. Bakkaloğlu,et al.  Disruption of PTPRO causes childhood-onset nephrotic syndrome. , 2011, American journal of human genetics.

[4]  B. Tazón-Vega,et al.  Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[5]  C. Antignac,et al.  Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. , 2009, Kidney international.

[6]  F. Hildebrandt,et al.  Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. , 2008, Journal of the American Society of Nephrology : JASN.

[7]  P. Kimmel,et al.  NPHS2 variation in sporadic focal segmental glomerulosclerosis. , 2007, Journal of the American Society of Nephrology : JASN.

[8]  F. Hildebrandt,et al.  Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[9]  J. Krieger,et al.  NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis. , 2006, Journal of nephrology.

[10]  D. Bowden,et al.  Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. , 2005, Kidney international.

[11]  O. Gribouval,et al.  In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutation. , 2004, Kidney international.

[12]  O. Gribouval,et al.  NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. , 2004, Kidney international.

[13]  A. Bakkaloğlu,et al.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[14]  F. Scolari,et al.  Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. , 2003, Kidney international.

[15]  R. Kalluri,et al.  NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. , 2002, The Journal of clinical investigation.

[16]  F. Hildebrandt,et al.  Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. , 2002, Journal of the American Society of Nephrology : JASN.

[17]  G. Ghiggeri,et al.  Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. , 2001, Journal of the American Society of Nephrology : JASN.

[18]  Corinne Antignac,et al.  NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.